Self Focus in Bipolar Disorder: A Functional Magnetic Resonance Imaging (fMRI) Study
An fMRI Study of Self Processing and Self Focus in Major Depression and Bipolar Disorder
2 other identifiers
observational
32
1 country
1
Brief Summary
The investigators propose to examine both resting state activity and functional activity during rumination and during self-processing to study the relationship between neural correlates of rumination/self-focus and self-processing in major depression and bipolar disorder.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jan 2013
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2013
CompletedFirst Submitted
Initial submission to the registry
September 24, 2014
CompletedFirst Posted
Study publicly available on registry
October 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2020
CompletedSeptember 1, 2021
August 1, 2021
7 years
September 24, 2014
August 31, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Functional Magnetic Resonance Imaging (fMRI) to examine self processing and self focus
Functional Magnetic Resonance Imaging (fMRI) will be used to look at the neuroanatomy of self processing and self focus.
Participants will be analyzed as quickly as possible after a screening visit, an expected average of 2 weeks
Study Arms (3)
Bipolar Disorder
Clinical status will be determined using the Mini International Neuropsychiatric Interview (M.I.N.I) for 20 patients with bipolar disorder (BPAD).
Major Depressive Disorder
Clinical status will be determined using the Mini International Neuropsychiatric Interview (M.I.N.I) for 20 patients with major depression (MDD).
Healthy Control
Clinical status will be determined using the Mini International Neuropsychiatric Interview (M.I.N.I) for 20 normal, healthy volunteers.
Interventions
Imaging will be performed on a 3T Siemens Trio scanner. Each MRI scanning session will last no more than 90 minutes.
Eligibility Criteria
Healthy controls will be recruited through email announcements at MGH, internet website at Harvard, and flyers posted at the Massachusetts General Hospital and in the community (e.g., community centers, public libraries, coffee shops, restaurants, and laundromats). Subjects with major depression will be recruited through the Depression Clinic and Research Program at MGH and flyers posted at MGH. Subjects with bipolar disorder will be recruited through the Bipolar Clinic and Research Program at MGH and flyers posted at MGH.
You may qualify if:
- Right-handed (as determined by the Handedness Inventory; Oldfield, 1971)
- Normal or corrected-to normal vision and hearing
You may not qualify if:
- Any current or past psychiatric history
- Significant medical, psychiatric or neurological illness
- Currently taking antidepressants, mood stabilizers, or benzodiazepines
- Positive MR screen (e.g., metal implant, claustrophobia, etc)
- Current diagnosis of MDD
- Right-handed (as determined by the Handedness Inventory; Oldfield, 1971)
- Normal or corrected-to normal vision and hearing
- If a history of substance abuse, at least 6 months in remission
- Current suicidal ideation or history of suicide attempts
- Positive MR screen (e.g., metal implant, claustrophobia, etc)
- Current diagnosis of BPAD
- Right-handed (as determined by the Handedness Inventory; Oldfield, 1971)
- Normal or corrected-to normal vision and hearing
- If a history of substance abuse, at least 6 months in remission
- Current suicidal ideation or history of suicide attempts
- +1 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sharmin Ghaznavi, M.D., Ph.D.
Massachusetts General Hospital
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Staff Psychiatrist
Study Record Dates
First Submitted
September 24, 2014
First Posted
October 1, 2014
Study Start
January 1, 2013
Primary Completion
January 1, 2020
Study Completion
January 1, 2020
Last Updated
September 1, 2021
Record last verified: 2021-08